Pediatric Asthma remains one of the most common chronic childhood conditions worldwide, affecting millions of children and significantly influencing daily activities, school attendance, sleep quality, and overall wellbeing. This session provides an in-depth exploration of asthma pathophysiology, triggers, diagnostic evaluation, and long-term management strategies tailored to infants, children, and adolescents. Clinicians often seek comprehensive updates from a specialised pediatric asthma conference to navigate evolving guidelines, biologic therapies, and personalised care models. Participants will explore how genetic predisposition, airway inflammation, viral infections, allergen exposures, pollution, and comorbidities converge to shape asthma severity and symptom patterns across childhood.

A major focus is creating structured pediatric asthma care pathways that emphasise early diagnosis, accurate severity classification, and proactive follow-up. Case discussions highlight common challenges such as recurrent wheeze in early childhood, difficulty distinguishing asthma from viral bronchiolitis, interpreting spirometry results, and managing exercise-induced symptoms. Attendees will review strategies for optimising inhaler technique, assessing adherence, addressing steroid concerns, and tailoring action plans that empower families to recognise worsening symptoms and intervene early.

The session will also explore acute exacerbation management, including bronchodilator therapy, systemic steroids, oxygen support, and escalation protocols for emergency settings. Participants will review indications for referral to specialists, criteria for advanced therapies, and approaches for children with poor control despite regular treatment. The discussion includes non-pharmacologic interventions such as allergen avoidance, weight management, airway clearance strategies, and exercise promotion.

Global perspectives address disparities in diagnostic access, environmental triggers, medication affordability, and school preparedness. Attendees will analyse how social determinants—housing quality, smoke exposure, healthcare accessibility, and pollution—shape asthma burden. The session emphasises culturally sensitive communication and shared decision-making to support families navigating chronic disease management.

Participants will also learn how digital tools such as symptom-tracking apps, remote spirometry, and telehealth visits can enhance monitoring and support continuity of care. The importance of education is reinforced throughout, focusing on building family confidence, reducing stigma, and ensuring safe participation in school and physical activities. The session concludes with forward-looking insights on biologics, biomarkers, personalised therapy, and early-life prevention strategies.